Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival
- PMID: 16411013
- DOI: 10.1007/s00268-005-0270-z
Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival
Abstract
Objectives: Extrathyroid extension has been recognized as a prognostic factor in papillary thyroid carcinoma. In the most recent version of the UICC TNM classification system, extrathyroid extension has been classified into two grades, minimal extension (extension to sternothyroid muscle or perithyroid soft tissues) and massive extension (extension to subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve). In this study, we investigated the prognostic significance of each of the two types of extension.
Patients and methods: One thousand and sixty-seven patients with papillary thyroid carcinoma without distant metastasis at surgery, who underwent surgical treatment in Kuma hospital between 1990 and 1995 and had been followed postoperatively for 60 months or more, were enrolled in this study. The grading of extrathyroid extension was based on both pathological findings and intraoperative surgical findings.
Results: In univariate analysis, although patients with massive extension showed a significantly worse relapse-free survival (RFS) rate than those with no or minimal extension (P < 0.0001), there was no difference in the RFS rate between patients with no extension and those with minimal extension. Among patients with massive extension, the RFS rate tended to be worse in those with posterior extension than in those with anterior extension (P = 0.0562). Furthermore, the RFS rate of patients with massive posterior extension only to the recurrent nerve demonstrated a better RFS rate than those with extension to other posterior organs (P = 0.0052). Multivariate analysis demonstrated that massive extrathyroid extension is recognized as an independent prognostic factor for RFS (P = 0.0003).
Conclusions: These findings suggest that (1) upgrading of T category for tumors with massive extension is appropriate, whereas that for tumors with only minimal extension is not, and (2) careful surgical treatment and postoperative follow-up are required for tumors with massive extension to posterior organs other than the recurrent laryngeal nerve.
Similar articles
-
Prognostic values of clinical lymph node metastasis and macroscopic extrathyroid extension in papillary thyroid carcinoma.Endocr J. 2014;61(8):745-50. doi: 10.1507/endocrj.ej14-0138. Epub 2014 Apr 17. Endocr J. 2014. PMID: 24739332 Review.
-
Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck.World J Surg. 2011 Apr;35(4):767-72. doi: 10.1007/s00268-010-0924-3. World J Surg. 2011. PMID: 21181469
-
[Indication and extent of cervical lymph node dissection in differentiated thyroid carcinoma].Zentralbl Chir. 2011 Aug;136(4):364-73. doi: 10.1055/s-0030-1247462. Epub 2010 Aug 13. Zentralbl Chir. 2011. PMID: 20711956 Review. German.
-
Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma.World J Surg. 2007 Jun;31(6):1194-201. doi: 10.1007/s00268-007-9042-2. World J Surg. 2007. PMID: 17431714
-
Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45 years.Surg Today. 2006;36(1):12-8. doi: 10.1007/s00595-005-3090-8. Surg Today. 2006. PMID: 16378187
Cited by
-
Single Institution Experience in the Management of Locally Advanced (pT4) Differentiated Thyroid Carcinomas.Ann Surg Oncol. 2024 May 3. doi: 10.1245/s10434-024-15356-z. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38700801
-
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up.Biomedicines. 2024 Feb 2;12(2):350. doi: 10.3390/biomedicines12020350. Biomedicines. 2024. PMID: 38397952 Free PMC article.
-
The impact of microscopic extrathyroidal extension on the clinical outcome of classic subtype papillary thyroid microcarcinoma: a multicenter study.Endocrine. 2024 Mar;83(3):700-707. doi: 10.1007/s12020-023-03533-1. Epub 2023 Sep 22. Endocrine. 2024. PMID: 37736822
-
Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.J Endocrinol Invest. 2024 Jan;47(1):115-129. doi: 10.1007/s40618-023-02129-w. Epub 2023 Jun 9. J Endocrinol Invest. 2024. PMID: 37294407
-
Causal inference between aggressive extrathyroidal extension and survival in papillary thyroid cancer: a propensity score matching and weighting analysis.Front Endocrinol (Lausanne). 2023 May 24;14:1149826. doi: 10.3389/fendo.2023.1149826. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37293504 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical